Saik Andrew - Insider Non-Derivative Transactions at INTERCEPT PHARMACEUTICALS, INC. (ICPT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 8, 2023, Saik Andrew's relationship to INTERCEPT PHARMACEUTICALS, INC. (ICPT) is Officer (EVP & Chief Financial Officer), and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ICPT insiders.
Data Source: SEC.
Saik Andrew - Insider Non-Derivative Transactions of ICPT Common Stock
Saik Andrew - Insider Non-Derivative Transactions at ICPT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 9, 2023 | U -- (Common Stock) | 23021 | 19 | 0 |
| Nov 9, 2023 | Disposition -- (Common Stock) | 45244 | 19 | 0 |
| Sep 22, 2023 | F -- (Common Stock) | 908 | 10.8 | 68265 |
| Jun 22, 2023 | F -- (Common Stock) | 908 | 11.74 | 69173 |
| Mar 22, 2023 | F -- (Common Stock) | 909 | 14.19 | 70081 |
| Jan 28, 2023 | Acquisition -- (Common Stock) | 14700 | 0 | 70990 |
| Jan 1, 2023 | F -- (Common Stock) | 718 | 12.37 | 56290 |